Direktorat Registrasi ObatValid

TADALAFIL

BPOM Number: GKL2531552417C1
Approved: 29 October 2025
Expiry: 28 October 2030
Form: TABLET SALUT SELAPUT

About This Registration

TADALAFIL is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2531552417C1. Its current registration status is Valid, with the licence valid until 28 October 2030. The product is registered to PRATAPA NIRMALA - INDONESIA. BPOM first approved this registration in October 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 1 STRIP @ 4 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

PRATAPA NIRMALA - INDONESIA
KOTA TANGERANG
NPWP: 013025754073000
owner
View profile →

Manufacturing Sites

PRATAPA NIRMALA - INDONESIA
KOTA TANGERANG
primary
View profile →

Ingredients (1)

TADALAFIL

Market Intelligence

Owner Portfolio: PRATAPA NIRMALA - INDONESIA holds 436 BPOM registrations
Manufacturer Scale: PRATAPA NIRMALA - INDONESIA produces 436 registered products
Registration Age: Registered for 8 months

FDA Cross-Reference

via openFDA

Generic Name: TADALAFIL
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?